Cargando…
A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106172/ https://www.ncbi.nlm.nih.gov/pubmed/36805548 http://dx.doi.org/10.1097/CM9.0000000000002442 |
| _version_ | 1785026370188869632 |
|---|---|
| author | Liu, Mingsheng Yao, Xiaoli Huang, Xusheng Shang, Huifang Fan, Dongsheng He, Jia Cui, Liying |
| author_facet | Liu, Mingsheng Yao, Xiaoli Huang, Xusheng Shang, Huifang Fan, Dongsheng He, Jia Cui, Liying |
| author_sort | Liu, Mingsheng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10106172 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101061722023-04-17 A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis Liu, Mingsheng Yao, Xiaoli Huang, Xusheng Shang, Huifang Fan, Dongsheng He, Jia Cui, Liying Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-02-05 2023-02-20 /pmc/articles/PMC10106172/ /pubmed/36805548 http://dx.doi.org/10.1097/CM9.0000000000002442 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Correspondence Liu, Mingsheng Yao, Xiaoli Huang, Xusheng Shang, Huifang Fan, Dongsheng He, Jia Cui, Liying A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis |
| title | A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis |
| title_full | A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis |
| title_fullStr | A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis |
| title_full_unstemmed | A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis |
| title_short | A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis |
| title_sort | multicenter, randomized, double blind, placebo-controlled clinical trial of dl-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106172/ https://www.ncbi.nlm.nih.gov/pubmed/36805548 http://dx.doi.org/10.1097/CM9.0000000000002442 |
| work_keys_str_mv | AT liumingsheng amulticenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT yaoxiaoli amulticenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT huangxusheng amulticenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT shanghuifang amulticenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT fandongsheng amulticenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT hejia amulticenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT cuiliying amulticenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT liumingsheng multicenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT yaoxiaoli multicenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT huangxusheng multicenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT shanghuifang multicenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT fandongsheng multicenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT hejia multicenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis AT cuiliying multicenterrandomizeddoubleblindplacebocontrolledclinicaltrialofdl3nbutylphthalideintreatmentofamyotrophiclateralsclerosis |